Restoration of Reproductive Hormone Concentrations in a Male Neutered Dog Improves Health: A Case Study
- PMID: 34332118
- DOI: 10.1016/j.tcam.2021.100565
Restoration of Reproductive Hormone Concentrations in a Male Neutered Dog Improves Health: A Case Study
Abstract
This case study reports on the use of hormone therapy to treat a dog with a range of physical and behavioral signs that began after gonadectomy. A male mixed breed dog neutered at 7 months of age presented at 1 year with health issues impacting quality of life. Reduced mobility, limping, rapid weight gain, and fear of unfamiliar people were treated over the next 3 years with trials of pain medication, joint supplements, thyroxine, antidepressant, and significant diet restrictions. Frequent carprofen administration and daily joint supplements reduced limping, but mobility was still poor. Weight stabilized on a strict diet but fear and anxiety responses to strangers continued to worsen. Hormone restoration therapy was initiated when the dog was almost 4 years of age. Weekly subcutaneous administration of testosterone cypionate (0.5 mg/kg) significantly reduced pain and increased muscle mass, thereby improving mobility. However, supraphysiologic concentrations of luteinizing hormone were not reduced with testosterone therapy so a gonadotropin-releasing hormone agonist was implanted. After hormone restoration, appetite was reduced, and anxiety and fear behaviors became manageable. The testosterone and gonadotropin-releasing hormone agonist treatment was easily administered, had no known side effects, and the owners were pleased with the outcome.
Keywords: canine; gonadectomy; hormone therapy; luteinizing hormone; neuter; testosterone.
Copyright © 2021 The Author(s). Published by Elsevier Inc. All rights reserved.
Similar articles
-
Effects of gonadotropin-releasing hormone administration on the pituitary-gonadal axis in male and female dogs before and after gonadectomy.Theriogenology. 2012 Mar 15;77(5):967-78. doi: 10.1016/j.theriogenology.2011.10.003. Epub 2011 Dec 6. Theriogenology. 2012. PMID: 22153274
-
Changes in plasma luteinizing hormone, testosterone and estradiol-17 beta levels and semen quality after injections of gonadotropin releasing hormone agonist and human chorionic gonadotropin in three dogs with oligozoospermia and two dogs with azoospermia.Anim Reprod Sci. 1997 May;47(1-2):157-67. doi: 10.1016/s0378-4320(97)00001-8. Anim Reprod Sci. 1997. PMID: 9233515
-
Response to gonadotrophin-releasing hormone by the intact male dog: serum testosterone, luteinizing hormone and follicle-stimulating hormone.J Reprod Fertil Suppl. 1993;47:335-41. J Reprod Fertil Suppl. 1993. PMID: 8229946
-
Gonadectomy in immature dogs: effects on skeletal, physical, and behavioral development.J Am Vet Med Assoc. 1991 Apr 1;198(7):1193-203. J Am Vet Med Assoc. 1991. PMID: 2045340
-
Effect of 131I-induced hypothyroidism on indices of reproductive function in adult male dogs.J Vet Intern Med. 1999 Mar-Apr;13(2):104-10. doi: 10.1892/0891-6640(1999)013<0104:eoihoi>2.3.co;2. J Vet Intern Med. 1999. PMID: 10225599 Clinical Trial.
Cited by
-
Impaired Testicular Function without Altering Testosterone Concentration Using an Anti-Follicular-Stimulating Hormone Receptor (Anti-FSHr) Single-Chain Variable Fragment (scFv) in Long-Tailed Macaques (Macaca fascicularis).Animals (Basel). 2023 Jul 12;13(14):2282. doi: 10.3390/ani13142282. Animals (Basel). 2023. PMID: 37508065 Free PMC article.
-
Obesity, inflammation, and cancer in dogs: Review and perspectives.Front Vet Sci. 2022 Oct 3;9:1004122. doi: 10.3389/fvets.2022.1004122. eCollection 2022. Front Vet Sci. 2022. PMID: 36262532 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
